Search Grant Opportunities

Expanded Surveillance for Pediatric Infectious Diseases

ID: RFA-IP-27-035 • Type: Forecasted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Analyze Opportunity
Generate a Draft
Loading

Description

Updated:

The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.

In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.

Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.

This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.

Component A Core Component (Required)

  • Support inpatient and emergency department pediatric surveillance
  • Follow the standardized protocol established by CDC

Optional Components

  • Component B: Support outpatient pediatric surveillance
  • Component C: Study immune response and infection
  • Component D: Study immune response and immunization

Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.

Findings of this NOFO will:

  • Improve best practices for diagnosis and treatment protocols
  • Inform prevention product recommendations
  • Guide public health strategies
  • Reduce viral illness-associated hospitalizations and healthcare utilization among children

The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.

In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.

Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.

This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.

Component A Core Component (Required)

  • Support inpatient and emergency department pediatric surveillance
  • Follow the standardized protocol established by CDC

Optional Components

  • Component B: Support outpatient pediatric surveillance
  • Component C: Study immune response and infection
  • Component D: Study immune response and immunization

Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.

Findings of this NOFO will:

  • Improve best practices for diagnosis and treatment protocols
  • Inform prevention product recommendations
  • Guide public health strategies
  • Reduce viral illness-associated hospitalizations and healthcare utilization among children

Overview

On 7/28/26 Centers for Disease Control and Prevention forecasted grant opportunity RFA-IP-27-035 for Expanded Surveillance for Pediatric Infectious Diseases with funding of $40.0 million. The grant will be issued under grant program 93.083 Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases. It is expected that 7 total grants will be made worth between $850,000 and $1.1 million.

Timing

Forecast Posted Date
Est. Application Posting Date
Est. Synopsis Response Date
Forecasted
Last Updated
Version
3
Archive Date

Eligibility

Eligible Applicants
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Special district governments
City or township governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Independent school districts
For profit organizations other than small businesses

Award Sizing

Ceiling
$1,140,000
Floor
$850,000
Estimated Program Funding
$40,000,000
Estimated Number of Grants
7

Contacts

Contact
Jamal Bankhead
Contact Email

Documents

Posted documents for RFA-IP-27-035

Opportunity Assistant


Analyze Opportunity

Generate a Draft

Potential Applicants and Partners

Awardees that have recently won grants similar to RFA-IP-27-035

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-IP-27-035

Experts for Expanded Surveillance for Pediatric Infectious Diseases

Recommended subject matter experts available for hire